Related content

Do Antiphospholipid Antibodies Interfere with Tissue Factor Pathway Inhibitor? - Isotype distribution and clinical significance in a series of 92 patients

By Jacobsen E.M.   Sandset P.M.   Wisloff F.  

Thrombosis Research, Vol. 94, Iss. 4, 1999-05 ,pp. : 213-220

Elsevier

Access to resources Recommend Favorite

Prevalence of hyperhomocysteinemia and the MTHFR C677T polymorphism in patients with arterial and venous thrombosis from North Western Russia

By Shmeleva V.M.   Kapustin S.I.   Papayan L.P.   Sobczynska-Malefora A.   Harrington D.J.   Savidge G.F.  

Thrombosis Research, Vol. 111, Iss. 6, 2003-01 ,pp. : 351-356

Elsevier

Access to resources Recommend Favorite

Val/Leu²⁴⁷ and Trp/Ser³¹⁶ polymorphisms in β₂ glycoprotein I and their association with thrombosis in unselected Chilean patients

By Palomo Iván   Pereira Jaime   Alarcón Marcelo   Vásquez Marcela   Pinochet Carmen   Poblete Fernando   Mendez Evelyn   Sandoval Jeannette   Vidal Rolando   Pierangeli Silvia  

Clinical Rheumatology, Vol. 26, Iss. 3, 2007-03 ,pp. : 302-307

Springer Publishing Company

Access to resources Recommend Favorite

FACTOR V LEIDEN INCREASES THE RISK OF THROMBOSIS IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES

By Simantov R.   Lo S.K.   Salmon J.E.   Sammaritano L.R.   Silverstein R.L.  

Thrombosis Research, Vol. 84, Iss. 5, 1996-12 ,pp. : 361-365

Elsevier

Access to resources Recommend Favorite

Analysis of 45 Episodes of Arterial Occlusive Disease in Japanese Patients with Congenital Protein C Deficiency - Prevalence in patients with a history of venous thrombosis and criteria for rational patient screening

By Sakata T.   Kario K.   Katayama Y.   Matsuyama T.   Kato H.   Miyata T.  

Thrombosis Research, Vol. 94, Iss. 2, 1999-04 ,pp. : 69-78

Elsevier

Access to resources Recommend Favorite